Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Detection of mutant p53 using field-effect transistor biosensor.

Han SH, Kim SK, Park K, Yi SY, Park HJ, Lyu HK, Kim M, Chung BH.

Anal Chim Acta. 2010 Apr 14;665(1):79-83. doi: 10.1016/j.aca.2010.03.006.

PMID:
20381694
2.

Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.

Suad O, Rozenberg H, Brosh R, Diskin-Posner Y, Kessler N, Shimon LJ, Frolow F, Liran A, Rotter V, Shakked Z.

J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063.

PMID:
18996393
3.
5.

Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding.

Wölcke J, Reimann M, Klumpp M, Göhler T, Kim E, Deppert W.

J Biol Chem. 2003 Aug 29;278(35):32587-95.

6.

Detection of TP53 mutation using a portable surface plasmon resonance DNA-based biosensor.

Jiang T, Minunni M, Wilson P, Zhang J, Turner AP, Mascini M.

Biosens Bioelectron. 2005 Apr 15;20(10):1939-45.

PMID:
15741061
7.

An FET-type charge sensor for highly sensitive detection of DNA sequence.

Kim DS, Jeong YT, Park HJ, Shin JK, Choi P, Lee JH, Lim G.

Biosens Bioelectron. 2004 Jul 30;20(1):69-74.

PMID:
15142578
8.

Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability.

Nichols NM, Matthews KS.

Biochemistry. 2002 Jan 8;41(1):170-8.

PMID:
11772014
9.

Mutational analysis of the p53 core domain L1 loop.

Zupnick A, Prives C.

J Biol Chem. 2006 Jul 21;281(29):20464-73.

10.

Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation.

Ishimaru D, Ano Bom AP, Lima LM, Quesado PA, Oyama MF, de Moura Gallo CV, Cordeiro Y, Silva JL.

Biochemistry. 2009 Jul 7;48(26):6126-35. doi: 10.1021/bi9003028.

PMID:
19505151
11.

Activation of the cryptic DNA binding function of mutant forms of p53.

Hupp TR, Meek DW, Midgley CA, Lane DP.

Nucleic Acids Res. 1993 Jul 11;21(14):3167-74.

12.

Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Nie Y, Li HH, Bula CM, Liu X.

Mol Cell Biol. 2000 Feb;20(3):741-8.

13.

Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.

Bargonetti J, Reynisdóttir I, Friedman PN, Prives C.

Genes Dev. 1992 Oct;6(10):1886-98.

14.

Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.

Halazonetis TD, Davis LJ, Kandil AN.

EMBO J. 1993 Mar;12(3):1021-8.

15.

Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.

Merabet A, Houlleberghs H, Maclagan K, Akanho E, Bui TT, Pagano B, Drake AF, Fraternali F, Nikolova PV.

Biochem J. 2010 Mar 29;427(2):225-36. doi: 10.1042/BJ20091888.

PMID:
20113312
16.

DNA bending due to specific p53 and p53 core domain-DNA interactions visualized by electron microscopy.

Cherny DI, Striker G, Subramaniam V, Jett SD, Palecek E, Jovin TM.

J Mol Biol. 1999 Dec 10;294(4):1015-26.

PMID:
10588903
17.

Sequence-specific interaction of a conformational domain of p53 with DNA.

Srinivasan R, Roth JA, Maxwell SA.

Cancer Res. 1993 Nov 15;53(22):5361-4.

18.

The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53.

Gobert C, Skladanowski A, Larsen AK.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10355-60.

19.

Detection of p53 gene mutation by using a novel biosensor based on localized surface plasmon resonance.

Duan RQ, Yuan JL, Yang H, Luo XG, Xi MR.

Neoplasma. 2012;59(3):348-53. doi: 10.4149/neo_2012_045.

PMID:
22329850
20.

Specific binding of MAR/SAR DNA-elements by mutant p53.

Müller BF, Paulsen D, Deppert W.

Oncogene. 1996 May 2;12(9):1941-52.

PMID:
8649855
Items per page

Supplemental Content

Support Center